NCT06632730

Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain

Therapeutic Management and Current Situation Related to the Use of Resources and Costs of Spinal Muscular Atrophy (SMA) in Spain: A Retrospective, Multicenter Analysis Based on Medical Record Review. TREaSURE Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 69 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 14 Years
• Healthy volunteers: Not accepted

Summary

An observational, retrospective, cross-sectional, multicenter study. Real-world data were obtained from medical records of Spanish public hospitals (9 hospitals).

Conditions

• Spinal Muscular Atrophy Type I
• Spinal Muscular Atrophy Type II

Timeline

• Start date: 2023-07-05
• Primary completion: 2023-11-20
• Completion: 2023-11-20
• First posted: 2024-10-09
• Last updated: 2024-10-09

Locations

1 site across 1 country: United States